| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 69.2% | 27/39 |
| Female | 30.8% | 12/39 |
| Indifferent | 0% | 0/39 |
| Unknown | 0% | 0/39 |
| General | ||
| 2.6% | 1/39 | |
| 5.1% | 2/39 | |
| 2.6% | 1/39 | |
| 30.8% | 12/39 | |
| 23.1% | 9/39 | |
| 25.6% | 10/39 | |
| 89.7% | 35/39 | |
| 97.4% | 38/39 | |
| 94.9% | 37/39 | |
| 84.2% | 32/38 | |
| Neurology | ||
| 71.8% | 28/39 | |
| 97.4% | 38/39 | |
| 46.2% | 18/39 | |
| Facial abnormalities | ||
| 33.3% | 13/39 | |
| 84.6% | 33/39 | |
| 84.6% | 33/39 | |
| 76.9% | 30/39 | |
| Visual and hearing impairments | ||
| 7.7% | 3/39 | |
| 56.4% | 22/39 | |
| Heart | ||
| 25.6% | 10/39 | |
| Pulmonary | ||
| 5.4% | 2/37 | |
| Gastrointestinal | ||
| 12.8% | 5/39 | |
| Urogenital | ||
| 35.9% | 14/39 | |
| Skeleton | ||
| 35.9% | 14/39 | |
| Skin / Hair / Nails | ||
| 61.5% | 24/39 | |
| Endocrine / Immunological / Metabolic | ||
| 2.6% | 1/39 | |
| 2.6% | 1/39 | |
| 15.4% | 6/39 | |
| Neoplasia | ||
| Neoplasia | 0% | 0/39 |
| Inheritance | ||
| 89.7% | 35/39 | |
